Autolus Therapeutics (AUTL) Amortization of Deferred Charges (2022 - 2023)
Autolus Therapeutics posted quarterly Amortization of Deferred Charges of $5.0 million for Q2 2023, up 174.13% year-on-year from $1.8 million in Q2 2022, and up 1.1% on a QoQ basis from $4.9 million in Q1 2023.
Autolus Therapeutics (AUTL) has 2 years of Amortization of Deferred Charges data on file, last reported at $5.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.96 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.79 Mn |